ArticleInternational journal of clinical oncology2023

The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer.

Toshiki Oka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.